Cargando…
Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury
BACKGROUND: Acute lung injury (ALI) is a life-threatening condition that fundamentally results from inflammation and edema in the lung. There are no effective treatments available for clinical use. Previously, we found that as a leakage blocker CU06-1004 prevents endothelial barrier disruption and e...
Autores principales: | Kim, Yeomyeong, Bae, Cho-Rong, Kim, Dongyeop, Kim, Hyejeong, Lee, Sunghye, Zhang, Haiying, Noh, Minyoung, Kim, Young-Myeong, Mochizuki, Naoki, Kwon, Young-Guen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078077/ https://www.ncbi.nlm.nih.gov/pubmed/37024954 http://dx.doi.org/10.1186/s12950-023-00338-x |
Ejemplares similares
-
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model
por: Kim, Hyejeong, et al.
Publicado: (2023) -
CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction
por: Kim, Ye-Seul, et al.
Publicado: (2020) -
CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome
por: Park, Songyi, et al.
Publicado: (2023) -
CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells
por: Park, Songyi, et al.
Publicado: (2021) -
CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia–reperfusion injury
por: Zhang, Haiying, et al.
Publicado: (2022)